C4 Therapeutics Inc Net Asset Quality Index
C4 Therapeutics Inc net asset quality index. C4 Therapeutics Inc (CCCC) has a Net Asset Quality Index of 68.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $359.40 Million minus total liabilities of $112.14 Million yields net assets of $247.26 Million. A higher index indicates a stronger, lower-leverage balance sheet. See CCCC book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of C4 Therapeutics Inc (2018–2025)
Net asset quality index of C4 Therapeutics Inc from 2018 to 2025. This chart shows how C4 Therapeutics Inc's Net Asset Quality Index has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the index stands at 68.8%, representing net assets of $247.26 Million against total assets of $359.40 Million USD. Check strategic asset allocation of C4 Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
C4 Therapeutics Inc Net Asset Quality Index by Year (2018–2025)
C4 Therapeutics Inc net asset quality index by year from 2018 to 2025. The table below presents the year-by-year Net Asset Quality Index for C4 Therapeutics Inc from 2018 to 2025, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of C4 Therapeutics Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.5% | $256.59 Million | $359.07 Million | $102.49 Million | ▲ +9.7 pp |
| 2024 | 61.8% | $215.99 Million | $349.60 Million | $133.62 Million | ▼ -3.6 pp |
| 2023 | 65.4% | $246.11 Million | $376.45 Million | $130.34 Million | ▼ -1.8 pp |
| 2022 | 67.1% | $289.23 Million | $430.84 Million | $141.61 Million | ▼ -9.7 pp |
| 2021 | 76.9% | $389.61 Million | $506.76 Million | $117.16 Million | ▲ +6.7 pp |
| 2020 | 70.2% | $280.79 Million | $400.14 Million | $119.35 Million | ▲ +164.8 pp |
| 2019 | -94.7% | $-111.96 Million | $118.26 Million | $230.22 Million | ▼ -40.2 pp |
| 2018 | -54.4% | $-79.75 Million | $146.49 Million | $226.24 Million | — |